Unusual single-stranded polyribonucleotides as potent anti-HIV agents.
Polyribonucleotides (PTMG and PMTI) containing 1-methyl-6-thioguanosine or 1-methyl-6-thioinosine, respectively, as the sole nucleoside component are shown to be potent inhibitors of various strains of HIV-1 and HIV-2 in a number of human lymphocyte and macrophage cell lines in tissue culture as well as in fresh human peripheral blood lymphocytes and macrophages. PMTI and PMTG exhibit potencies in the range of 10(-7)-10(-8) M in these systems. The polynucleotides are active against virus strains resistant to AZT and pyridinone derivatives. Both PMTI and PMTG are synergistic with AZT and with ddI, and both inhibit HIV reverse transcriptase at nanomolar concentrations. The polymers show little or no toxicity in human cell lines at the highest doses tested (100 micrograms/mL, or about 0.2-1 microM). This class of compounds represents a new lead in AIDS therapeutic drug discovery.
Broom
A D
AD
Department of Medicinal Chemistry, College of Pharmacy, University of Utah, Salt Lake City 84112, USA.
Agrawal
V K
VK
Tutonda
M G
MG
Fain
H D
HD
Buckheit
R W
RW
D000998:Antiviral Agents / Q000737:chemistry / Q000494:pharmacology*; D002460:Cell Line; D003588:Cytopathogenic Effect, Viral / Q000187:drug effects; D015726:Giant Cells; D015497:HIV-1 / Q000187:drug effects* / Q000472:pathogenicity; D015498:HIV-2 / Q000187:drug effects* / Q000472:pathogenicity; D006801:Humans; D009690:Nucleic Acid Conformation; D011131:Polyribonucleotides / Q000737:chemistry / Q000494:pharmacology*
D000998:Antiviral Agents; D011131:Polyribonucleotides